Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IngevityNGVT -2.21%62 14-Day RSI is 39.70 as of Aug. 20, 2026. GuruFocus rates NGVT with a GF Score™ of 62/100 and a GF Value™ of $46.12 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,652 Chemicals companies, Ingevity ranks better than 86.92% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-20), Ingevity's 14-Day RSI is 39.70.
The industry rank for Ingevity's 14-Day RSI or its related term are showing as below:
NGVT's 14-Day RSI is ranked better than 86.92% of 1652
companies
in the Chemicals industry
Industry Median: 49.185
vs NGVT: 39.70
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Ingevity 14-Day RSI Related Terms
NGVT vs CC, KWR, MTX: 14-Day RSI Comparison
For the Specialty Chemicals subindustry, Ingevity's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity 14-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Ingevity's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ingevity (NGVT) has a 14-Day RSI of 39.70 as of Aug. 20, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Ingevity and its competitors. According to the industry distribution chart, Ingevity ranks #216 out of 1652 companies in the Chemicals industry, placing it in the top 13.1%.
Is Ingevity's 14-Day RSI too high?
Ingevity's current 14-Day RSI is 39.70. The Chemicals industry median 14-Day RSI is 49.19. Ingevity's value of 39.70 is 19.3% below this industry median. Based on the distribution chart, Ingevity ranks #216 out of 1652 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Ingevity has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ingevity's 14-Day RSI compare to CC and KWR?
According to the Chemicals industry distribution chart, Ingevity ranks #216 out of 1652 companies for 14-Day RSI. This places Ingevity in the top 13% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.19. Ingevity's value of 39.70 is 19.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Chemicals company?
The median 14-Day RSI among Chemicals companies is 49.19, based on 1,652 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ingevity's current 14-Day RSI of 39.70 is 19.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Ingevity and its competitors. For the Chemicals industry, the median 14-Day RSI is 49.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ingevity's current 14-Day RSI is 39.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Based on GuruFocus' analysis, Ingevity (NGVT) is currently considered Significantly Overvalued. The stock's GF Value™ is $46.12, compared to a current price of $69.59 — trading 50.9% above its estimated fair value. The current 14-Day RSI is 39.70 and 19.3% below the Chemicals industry median of 49.19. Ingevity's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Ingevity (NGVT), the current 14-Day RSI is 39.70 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (NGVT) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of $69.59 is trading 50.9% above its estimated GF Value™ of $46.12.
GuruFocus considers Ingevity to be Significantly Overvalued.
Key valuation signals for NGVT:
14-Day RSI: 39.70
GF Value™: $46.12 vs. price of $69.59 (50.9% above fair value)
Industry Position: 19.3% below the Chemicals median (#216 of 1652)
No single metric tells the full story. See the NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score
Get the complete analysis for NGVT
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGVT has been successfully added to your 
